脾脏
血栓形成
沙门氏菌
生物
细菌
血小板
微生物学
免疫学
体内
炎症
病理
医学
内科学
遗传学
生物技术
作者
Nonantzin Beristain‐Covarrubias,Marisol Pérez-Toledo,Adriana Flores‐Langarica,Malou Zuidscherwoude,Jessica R. Hitchcock,Will M. Channell,Lloyd D. W. King,Mark R. Thomas,Ian R. Henderson,Julie Rayes,Steve P. Watson,Adam F. Cunningham
出处
期刊:Blood
[American Society of Hematology]
日期:2018-11-06
卷期号:133 (6): 600-604
被引量:42
标识
DOI:10.1182/blood-2018-08-867267
摘要
Abstract Thrombosis is a frequent, life-threatening complication of systemic infection associated with multiple organ damage. We have previously described a novel mechanism of inflammation-driven thrombosis induced by Salmonella Typhimurium infection of mice. Thrombosis in the liver develops 7 days after infection, persisting after the infection resolves, and is monocytic cell dependent. Unexpectedly, thrombosis was not prominent in the spleen at this time, despite carrying a similar bacterial burden as the liver. In this study, we show that thrombosis does occur in the spleen but with strikingly accelerated kinetics compared with the liver, being evident by 24 hours and resolving rapidly thereafter. The distinct kinetics of thrombosis and bacterial burden provides a test of the hypothesis that thrombi form in healthy vessels to trap or remove bacteria from the circulation, often termed immunothrombosis. Remarkably, despite bacteria being detected throughout infected spleens and livers in the early days of infection, immunohistological analysis of tissue sections show that thrombi contain very low numbers of bacteria. In contrast, bacteria are present throughout platelet aggregates induced by Salmonella in vitro. Therefore, we show that thrombosis develops with organ-specific kinetics and challenge the universality of immunothrombosis as a mechanism to capture bacteria in vivo.
科研通智能强力驱动
Strongly Powered by AbleSci AI